3[1]Trouillet JL, Chaster J, Vuagnat A, et al. Ventilator-associated pneumonia caused by potentially drug-resistant bacteria[J]. Am J Respir Crit Care Med, 1998,157: 531-539
5[3]Wu CL, Yang Die, Wang NY, et al. Quantitative culture of endotracheal aspirates in the diagnosis of ventilator-associated pneumonia in patients with treatment failure[J] Chest, 2002,122: 662-668
6[4]Kollef MH. Antimicrobial therapy of ventilator-associated pneumonia: how to select an appropiate drug regimen[J]. Chest, 1999,115:8-11
7[5]Luna CM, Vujacich P, Niederman MS, et al. Impact of BAL data on the therapy and outcome of ventilator-associated pneumonia [J]. Chest, 1997,111: 676-685
8[6]Alvarez-Lerma F. Modification of empiric antibiotic treatment in patients with pneumonia acquired in the intensive care unit[J].Intensive Care Med, 1996, 22: 387-394
9[7]Rello J, Gallego M, Mariscal D, et al. The value of routine microbial investigation in ventilator-associated pneumonia[J]. Am J Respir Crit Care Med, 1997,156:196-200
10Haddadin AS, Fappiano SA, Lipsett PA. Methicillin resist antstaphylococcus aureus (MRSA) in the intensive care unit. Postgrad Med J, 2002,78:385.
